[sc] Specialty Care Inline Portfolio & Lcm Strategy Lead

Pfizer Pfizer · Pharma · Tokyo, Japan

Pfizer is seeking a Specialty Care Inline Portfolio & LCM Strategy Lead in Japan to manage the end-to-end lifecycle and portfolio strategy for inline Specialty Care products. This role involves integrating LCM with portfolio strategy, managing new indications, formulations, and pre-LOE planning, and aligning global strategies with local market realities. The lead will also act as a project manager, develop portfolio roadmaps, support launches, and manage risks related to market and regulatory changes.

What you'd actually do

  1. Own the country-specific LCM strategy for inline products, aligned with Global / ICO LCM frameworks focusing on RD businesses (expected projects: new formulation, additional indications of RD business)
  2. Own and drive the inline Specialty Care portfolio strategy in Japan, ensuring prioritization of resources and initiatives across products.
  3. Support formulation or new indication launches or transitions (e.g., line extensions, formulation changes) in close collaboration with brand and functional teams, working closely with launch excellence team where applicable.
  4. Identify, track, and proactively mitigate portfolio- and LCM-critical risks, such as pricing erosion rule changes, substitution exposure, and access disruption.
  5. Assist SC commercial leads or brand leads, as well as SC TA lead at OP process to work closely with Finance team as an overall SC portfolio planning

Skills

Required

  • Strategic thinking
  • Cross-functional team leadership
  • Business case development
  • Financial acumen
  • Project management
  • Japanese language proficiency
  • English language proficiency

Nice to have

  • Brand strategy development
  • Portfolio strategy development
  • Market analysis
  • Customer insights
  • Pharmaceutical lifecycle management
  • Pricing
  • Access
  • Competitive dynamics
  • Launch preparation
  • Lifecycle transitions
  • Specialty care disease experience

What the JD emphasized

  • end-to-end lifecycle and portfolio strategy
  • new indication
  • new formulations
  • pre-LOE planning
  • portfolio-level strategic planning
  • sustained value delivery
  • proactively managing risks
  • identifying opportunities
  • financial impact
  • project manager (PMO)
  • project lead
  • single point of coordination
  • Global / ICO strategies
  • Japan-specific market realities
  • cross-functional teams
  • cohesive, forward-looking portfolio and lifecycle plans and execution
  • country-specific LCM strategy
  • Global / ICO LCM frameworks
  • RD businesses
  • pre-post LOE
  • formulation evolution
  • generic or biosimilar entry
  • LOE forecasting
  • I&I and RD product
  • organizational readiness
  • lifecycle transitions
  • internal alignment
  • communication planning
  • execution governance
  • inline Specialty Care portfolio strategy in Japan
  • prioritization of resources and initiatives
  • mid- to long-term portfolio roadmap
  • commercial, medical, access, and regulatory perspectives
  • Global / ICO portfolio and brand strategies
  • Japan-optimized plans
  • local pricing rules
  • access pathways
  • competitive landscape
  • SC commercial leads
  • brand leads
  • SC TA lead
  • OP process
  • Finance team
  • overall SC portfolio planning
  • formulation or new indication launches or transitions
  • line extensions
  • formulation changes
  • brand and functional teams
  • launch excellence team
  • market/regulation changes
  • portfolio- and LCM-critical risks
  • pricing erosion rule changes
  • substitution exposure
  • access disruption
  • clear options and recommendations
  • timely decision-making
  • country and above-market levels
  • Strong strategic thinking
  • connect portfolio, brand, and lifecycle perspectives
  • lead cross-functional teams without direct authority
  • drive alignment across diverse stakeholders
  • Team worker
  • High level of self-awareness, accountability, and agility
  • comfort operating in ambiguity and change
  • Learning agility
  • Willing to learn new things, new way of approaches, and learn from others
  • Influential leadership
  • Logical thinking and strategic mindset
  • Strong business case/financial case development skills
  • fair knowledge around financial acumen
  • Project management skills and experiences
  • Solid communication skills both in Japanese and in English at business level
  • some level of experience in brand and portfolio strategy development
  • grounded in market analysis and customer insights
  • some level of understanding of pharmaceutical lifecycle management
  • pricing, access, and competitive dynamics
  • 5+ years of experience in the pharmaceutical industry
  • marketing, portfolio strategy, or lifecycle management preferred
  • consultancy work at health care industries
  • launch preparation and/or major lifecycle transitions is highly preferred
  • any diseases in Specialty care is a plus
  • Business-level proficiency in Japanese and English (written and verbal)